Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma fibronectin: predictive factor in gestational hypertension?

C Arnaud1, C Chau, B Dizier

  • 1Laboratoire de Biochimie, Hôpital Nord, Marseille, France.

Pathologie-Biologie
|June 1, 1997
PubMed
Summary

Plasma fibronectin levels were higher in preeclampsia cases. A fibronectin concentration below 400 mg/l effectively excluded hypertension disorders of pregnancy, suggesting its use as an exclusion parameter.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific metabolic and oxidative stress profiles associated to myocardial infarct size in mice after exposure to intermittent hypoxia.

Free radical biology & medicine·2025
Same author

Can a virtual reality tool detect minor executive functions impairment in patients with multiple sclerosis?

Revue neurologique·2025
Same author

Psychometric properties of a French translation of the Functionality Appreciation Scale in French adults (FAS).

Body image·2024
Same author

Neurological disorders related to recreational nitrous oxide abuse: Two sides of the same coin.

Revue neurologique·2023
Same author

The house is a machine for everything: the role of the built environment in group homes during the COVID-19 pandemic.

Public health·2023
Same author

Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study.

The British journal of dermatology·2021

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Biomarker Research

Background:

  • Endothelial cell injury is a key feature in hypertensive disorders of pregnancy.
  • Fibronectin, a glycoprotein, is involved in cell adhesion and extracellular matrix formation.
  • Identifying reliable markers for early detection of preeclampsia is crucial for maternal and fetal health.

Purpose of the Study:

  • To assess plasma fibronectin as a marker for endothelial cell injury.
  • To evaluate fibronectin's utility in predicting preeclampsia.
  • To determine the diagnostic value of fibronectin in pregnancy-induced hypertension.

Main Methods:

  • Retrospective study conducted from November 1993 to March 1995.
  • Analysis of plasma fibronectin concentrations in 142 pregnant women (108 normal, 34 with preeclampsia).

Related Experiment Videos

  • Statistical comparison of fibronectin levels between normotensive and pre-eclamptic groups.

    • Main Results:

    • Plasma fibronectin concentrations were significantly elevated in women with preeclampsia (620 +/- 210 mg/l) compared to normotensive controls (390 +/- 130 mg/l).
    • A fibronectin level below 400 mg/l demonstrated a 96% negative predictive value for the non-development of hypertension.
    • Fibronectin showed potential as an exclusion marker rather than a predictive test for hypertensive disorders.

    Conclusions:

    • Fibronectin may serve as a valuable exclusion parameter for ruling out hypertensive disorders of pregnancy.
    • Elevated fibronectin levels correlate with preeclampsia, indicating its association with endothelial dysfunction.
    • Further research could explore fibronectin's role in the pathophysiology and management of pregnancy-related hypertension.